Literature DB >> 24316627

First-in-class guanylate cyclase stimulator approved for PAH.

Malini Guha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24316627     DOI： 10.1038/nbt1213-1064b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Changed hemodynamics in acute vasoreactivity testing: prognostic predictors in chronic thromboembolic pulmonary hypertension.

Authors:  Yan-Zhe Yu; Ping Yuan; Yi-Lan Yang; Yuan-Yuan Sun; Qin-Hua Zhao; Lan Wang; Rong Jiang; Wen-Hui Wu; Jing He; Jing-Hong Dai; Yuan Li; Bigyan Pudasaini; Jin-Ling Li; Su-Gang Gong; Wei-Ping Xie; Jin-Ming Liu
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 2.  The multifaceted roles of FOXM1 in pulmonary disease.

Authors:  Yumei Li; Feng Wu; Qi Tan; Mengfei Guo; Pei Ma; Xuan Wang; Shuai Zhang; Juanjuan Xu; Ping Luo; Yang Jin
Journal:  Cell Commun Signal       Date:  2019-04-16       Impact factor: 5.712

3.  Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth.

Authors:  Keyur Donda; Ronald Zambrano; Younghye Moon; Justin Percival; Ruben Vaidya; Fredrick Dapaah-Siakwan; Shihua Luo; Matthew R Duncan; Yong Bao; Luqing Wang; Ling Qin; Merline Benny; Karen Young; Shu Wu
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

4.  Druggability of Coronary Artery Disease Risk Loci.

Authors:  Vinicius Tragante; Daiane Hemerich; Mohammad Alshabeeb; Ingrid Brænne; Harri Lempiäinen; Riyaz S Patel; Hester M den Ruijter; Michael R Barnes; Jason H Moore; Heribert Schunkert; Jeanette Erdmann; Folkert W Asselbergs
Journal:  Circ Genom Precis Med       Date:  2018-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.